- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Rapid Dose Therapeutics Corp: Rapid Dose closes final tranche of financing | 1 | Stockwatch | ||
| Mi | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Closing of Final Tranche of Common Share Private Placement | 268 | Newsfile | Burlington, Ontario--(Newsfile Corp. - October 30, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") is pleased to announce that it has closed a second and final tranche of... ► Artikel lesen | |
| 02.10. | Rapid Dose Therapeutics Corp: Rapid Dose to issue 557,677 shares for debt | 3 | Stockwatch | ||
| 02.10. | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Payment in Shares for Interest on Secured Debt | 369 | Newsfile | Burlington, Ontario--(Newsfile Corp. - October 1, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the... ► Artikel lesen | |
| 17.09. | Rapid Dose Therapeutics Corp: Rapid Dose extends private placement to Oct. 29 | 4 | Stockwatch | ||
| 17.09. | Rapid Dose Therapeutics Corp.: Rapid Dose Provides Update on Common Share Private Placement | 436 | Newsfile | Burlington, Ontario--(Newsfile Corp. - September 16, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that further to its press release dated August 7, 2024... ► Artikel lesen | |
| 22.07. | Rapid Dose Therapeutics Corp: Rapid Dose closes $309,000 first tranche of financing | 4 | Stockwatch | ||
| 22.07. | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Closing of First Tranche of Common Share Private Placement | 242 | Newsfile | Burlington, Ontario--(Newsfile Corp. - July 22, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") is pleased to announce that it has closed a first tranche of its previously... ► Artikel lesen | |
| 03.07. | Rapid Dose Therapeutics Corp: Rapid Dose to issue 520,968 shares for note interest | 1 | Stockwatch | ||
| 03.07. | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics Announces Payment in Shares for Interest on Secured Debt | 470 | Newsfile | Burlington, Ontario--(Newsfile Corp. - July 2, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the... ► Artikel lesen | |
| 02.07. | Rapid Dose Therapeutics Corp: Rapid Dose loses $4.28-million in fiscal 2024 | 1 | Stockwatch | ||
| 02.07. | Rapid Dose Therapeutics GAAP EPS of -C$0.04, revenue of C$1.02M | 1 | Seeking Alpha | ||
| 02.07. | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics Reports Fiscal Year 2024 Financial Results | 235 | Newsfile | Burlington, Ontario--(Newsfile Corp. - July 2, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), is pleased to announce the filing of its financial results for the year ended... ► Artikel lesen | |
| 25.06. | Rapid Dose Therapeutics Corp: Rapid Dose receives $30,000 grant for vaccine study | 1 | Stockwatch | ||
| 25.06. | Rapid Dose Therapeutics Corp.: Rapid Dose Therapeutics Vaccine Delivery Study Receives Mitacs Accelerate Grant | 197 | Newsfile | Burlington, Ontario--(Newsfile Corp. - June 25, 2024) - Rapid Dose Therapeutics Corp. ("RDT" or the "Company") trading on the Canadian Securities Exchange ("CSE") under the symbol DOSE is pleased to... ► Artikel lesen | |
| 19.06. | Rapid Dose Therapeutics Corp: Rapid Dose Therapeutics extends $6M financing to Aug. 8 | 1 | Stockwatch | ||
| 19.06. | Rapid Dose Therapeutics Corp.: Rapid Dose Provides Update on Common Share Private Placement | 255 | Newsfile | Burlington, Ontario--(Newsfile Corp. - June 19, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that further to its press release dated May 8, 2024, regarding... ► Artikel lesen | |
| 31.05. | PTA-News: Rapid Dose Therapeutics Inc.: Rapid Dose Therapeutics Commits to NFL-Funded Clinical Trial Application | 309 | Dow Jones News | DJ PTA-News: Rapid Dose Therapeutics Inc.: Rapid Dose Therapeutics Commits to NFL-Funded Clinical Trial Application
Unternehmensmitteilung für den Kapitalmarkt
Burlington (pta/31.05.2024/11:16)... ► Artikel lesen | |
| 29.05. | Rapid Dose Therapeutics Corp: Rapid Dose to be in NFL-financed clinical trial | 1 | Stockwatch | ||
| 29.05. | Rapid Dose Therapeutics collaborates with NFL | 1 | The Market Herald Canada |
Seite:
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIONTECH | 101,20 | -0,98 % | Biontech-Partner top in Q3: Pfizer übertrifft Erwartungen und hebt Jahresprognose an | © Foto: Foto: Nicolas Maeterlinck/ - BELGA/dpaPfizer hat starke Ergebnisse für das dritte Quartal präsentiert, die sowohl beim Umsatz als auch beim bereinigten Gewinn deutlich über den Analystenschätzungen... ► Artikel lesen | |
| CORE ONE LABS | 0,079 | -100,00 % | XFRA LD6: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCORE ONE LABS INC.... ► Artikel lesen | |
| CLINUVEL | 8,400 | +0,54 % | Clinuvel Pharmaceuticals Aktie: Stabil trotz leichter Monatsverluste | Die Clinuvel Pharmaceuticals Aktie zeigt sich am 19. Oktober 2024 weitgehend unverändert bei 8,563 EUR. Trotz eines leichten Rückgangs von 1,10% im vergangenen Monat, behauptet sich das Papier des australischen... ► Artikel lesen | |
| BIONXT SOLUTIONS | 0,163 | -1,22 % | BioNxt reicht Patentanmeldungen auf nationaler Ebene für sublinguale Krebsmedikamente zur Behandlung von neurodegenerativen Autoimmunerkrankungen ein | VANCOUVER, BC / ACCESSWIRE / 29. Oktober 2024 - BioNxt Solutions Inc. ("BioNxt" oder das "Unternehmen") (CSE: BNXT / OTCQB: BNXTF / FWB: BXT) freut sich bekannt zu geben, dass das Unternehmen ein... ► Artikel lesen | |
| AMYRIS | - | - | BioMaP-Consortium Contracts Amyris to Support Domestic Medicines Supply | ||
| ATAI LIFE SCIENCES | 0,978 | -1,94 % | ATAI Life Sciences N.V. - 8-K, Current Report | ||
| VIDAC PHARMA | 0,505 | 0,00 % | Starker Kursanstieg! Was ist los bei Aixtron, HelloFresh und der Vidac Pharma Aktie? | Die Märkte setzen auf eine weitere Lockerung der Geldpolitik seitens der Notenbanken FED und EZB und dementsprechend notieren die Aktienindizes am Allzeithoch. Auch viele Aktien sind bereits gestiegen... ► Artikel lesen | |
| MUSTGROW BIOLOGICS | 1,095 | -6,01 % | Mustgrow Biologics CEO Corey Giasson interview at Cantech 24 | ||
| CARA THERAPEUTICS | 0,263 | -2,59 % | Cara Therapeutics, Inc.: Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica | - Oral difelikefalin did not demonstrate meaningful clinical benefit compared to placebo - - Company will discontinue clinical program in NP and explore strategic alternatives - STAMFORD, Conn., June... ► Artikel lesen | |
| REVIVE THERAPEUTICS | 0,001 | 0,00 % | Revive Therapeutics Ltd: Revive expects bucillamine study results by year-end | ||
| CYBIN | 9,250 | -0,54 % | CYBIN INC. - 6-K, Report of foreign issuer | ||
| SOL GLOBAL INVESTMENTS | 0,087 | -1,14 % | SOL Global Investments Corp.: SOL Global Announces Strategic Change with Investment Focus in Solana | Toronto, Ontario--(Newsfile Corp. - November 4, 2024) - SOL Global Investments Corp. (CSE: SOL) (OTC Pink: SOLCF) (FSE: 9SB) ("SOL" or "the Company") today announced a strategic shift by its wholly-owned... ► Artikel lesen | |
| AWAKN LIFE SCIENCES | 0,053 | -12,40 % | Awakn Life Sciences Corp.: Awakn Announces Opening of Four Additional AWKN-001 Phase 3 Trial Sites | Toronto, Ontario--(Newsfile Corp. - October 22, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company developing... ► Artikel lesen | |
| ARTELO BIOSCIENCES | 1,200 | +5,26 % | Artelo Biosciences Announces Acceptance of ART26.12 into the National Institutes of Health's "Preclinical Screening Platform for Pain" Program | ||
| LOBE SCIENCES | 0,003 | -28,57 % | Lobe Sciences Ltd (2): Lobe Sciences hires Enclave, Peak for financing |
Das Unternehmen RAPID DOSE THERAPEUTICS CORP kann der Branche Biotechnologie zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu RAPID DOSE THERAPEUTICS CORP finden Sie auf Wallstreet Online.
